60 Degrees Pharmaceuticals, Inc. SXTP
0.50 USD -0.04 (-7.05%)
Regular-session close
0.50 0.00 0.00%
After hours · Nov 19, 5:24 PM ET
0.50 Day range 0.5165
0.46 52-week range 8.62
- YTD
- -75.37%
- 1 year
- -88.10%
Benzinga news
benzinga.com 60 Degrees Q3 EPS $(0.75) Misses $(0.73) Estimate, Sales $233.235K Miss $300.000K Estimate 60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.73) by 2.74 percent. This is a 71.8 percent increase over losses of $(2.66)…
benzinga.com 60 Degrees Pharmaceutical Enters Sponsored Research Agreement With University Of Southern Mississippi To Assess The Potential Of Castanospermine In Nonclinical Models Of Alpha-Gal Syndrome The partnership leverages USM’s established vector biology research expertise and investigator insights into tick-borne disease. Under this agreement, 60 Degrees will underwrite the research and…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Axogen (NASDAQ:AXGN) stock rose 17.7% to $44.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q3 earnings report…benzinga.com 60 Degrees Pharma Reports Clinical, Molecular Results From First Five Completed Patients In Relapsing Babesiosis Expanded Access Study; All Five Completed Patients Report Clinical Improvement All five completed patients (100%) reported much or very much improved clinical outcomes and tested negative for Babesia on conventional PCR testsFour of five completed patients (80%) were negative…
